Saudi Film Commission launch its strategy to develop film and cinema sector    Dr. Al-Abdel Ali stresses failure to reach vaccination rates reason for global COVID surge    Qatar's Al-Attiyah heads field for MERC finale in Oman    Saudi Arabia Dakar Rally route unveiled; 430 vehicles to take part    Military Industries Corporation President Visits Egyptian Minister of State for Military Production    Specialists eye industry-related issues in first Saudi Translation Forum    SDRPY opens four model schools in Socotra    Jeddah Corniche Circuit attracts world attention as first Saudi Arabian GP nears    Launch of Fintech Tour Activities in Participation of SAMA, CMA and MCIT    GCC Secretary General Meets with Qatari Minister of Finance    Saudi Stock Exchange Main Index Ends Trading Lower at 10,787 Points    Dar AL-Hekma University Celebrates General Education    Residence, Exit, Re-entry and Visit Visas to Be Extended until 31/01/2022 Automatically Without Any Cost    South Africa 'punished' for detecting new Omicron variant    UK re-imposes face covering due to Omicron variant    Blinken commends S. Africa for quick detection of Omicron    UAE, China sign explanatory memorandum to boost customs, trade cooperation    Smarter digital power fundamental to meeting the Middle East's low-carbon ambitions, experts contend    stc pay ranked as one of the most popular digital only banks in the middle east    Al-Eryani: Projects funded by KSrelief in Marib contributes to alleviating suffering of displaced    Riyadh Season to host @Hack as biggest cybersecurity event in region    'Disability reminds us that there is no such thing as normal'    Bollywood superstar Salman Khan to dazzle Riyadh Season on Dec. 10    New Batch of Saudi Fuel Derivatives Grant Arrives in Hadramout, Mahra, Yemen    Saudi Arabia to Host 3rd Government Forum to Discuss Challenges of Combating Trafficking in Persons in ME 2021    Saudi Arabia welcomes Australia's intention to designate Hezbollah as 'terrorist organization'    Palestinian President Receives Jordanian Foreign Minister    Ministry of Industry and Mineral Resources Wins "Business Change and Transformation" Award from ICXA    Musical theater legend Sondheim dies aged 91    Indian embassy inaugurates international film festival    Sport minister to reveal details of Saudi Dakar Rally 2022    STC Group Wins 2021 Effie Middle East Gold Awards    Custodian of the Two Holy Mosques Condoles Russian President on Victims of an Accident inside a Coal Mine in Siberia    Brazil Records 12,392 New Cases of COVID-19    President, CEO of Saudi Arabian Fencing Federation to Participate in International Fencing Federation Congress    Al-Hilal Wins AFC Champions League 2021    United Through Sports World Virtual Youth Festival Kicks off Tomorrow in Turaif District    SAFF Announces First Female Coach for KSA's First Women's Team    First Full International Marathon in Saudi Arabia to be Held in March 2022    Riyadh Art Launches Tuwaiq International Sculpture Symposium 2021    Winter Wonderland Circus Amazes Audience with Thrilling Acrobatic Shows    Bollywood star's 'India got freedom in 2014' remark stirs controversy    23 Saudi women obtain favorable verdicts in 'adhl' lawsuits    Bride's fingerprint not required in revised e-marriage contract    Pilgrims Perform Dhuhr and Asr Prayers at Arafat Holy Site    Council of Senior Scholars: Muslim Brothers' Group Don't Represent Method of Islam, rather only Follows its Partisan Objectives, Violating our Graceful Religion    Eid Al-Adha Prayer Performed at the Grand Holy Mosque    Pilgrims Perform Dhuhr and Asr Prayers in Arafat Holy Site    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



Oxford University candidate vaccine is 70% effective
Published in The Saudi Gazette on 23 - 11 - 2020

The Oxford University's candidate coronavirus vaccine is 70.4% effective, according to preliminary data from Phase 3 trials.
The efficacy depended on the dose regimen, the university said in a statement, with the vaccine, which was developed with pharmaceutical company AstraZeneca, becoming 90% effective if administered at a half dose and then at a full dose and 62% effective if administered in two full doses.
There were no hospitalized or severe cases of the virus among those who received the vaccine, the university said in a statement.
"These findings show that we have an effective vaccine that will save many lives. Excitingly, we've found that one of our dosing regimens may be around 90% effective and if this dosing regimen is used, more people could be vaccinated with planned vaccine supply," said Professor Andrew Pollard, the chief investigator of the Oxford Vaccine Group.
It comes after the team announced last week that Phase 2 trials in healthy older adults showed the candidate vaccine is safe and provokes an immune response.
The phase 2 trial, which involved 560 adults including 240 over the age of 70, found that the vaccine causes few side effects and induces immune responses in both parts of the immune system in all age groups.
The news from Oxford comes after results showed that vaccines developed by Pfizer and Moderna were 95% effective. The vaccine developed by Pfizer and BioNTech was 94% effective in adults over the age of 65, who are more at risk for severe illness.
Some experts now say that a vaccine could be made available by the end of 2020 for healthcare workers and those who are more vulnerable to the virus.
The Oxford vaccine, though seemingly less effective than the Pfizer and Moderna ones, is made from a weakened cold virus that was genetically changed. It can be stored in a regular refrigerator instead of at ultra-cold temperatures like the Pfizer vaccine. — Euronews


Clic here to read the story from its source.